Get it on Google Play

NetraMark signs contract to analyze phase 2 depression trial data

March 11, 2026 7:00 AM EDT Send to a Friend
NetraMark Holdings Inc. (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) announced it signed a contract with a global biopharmaceutical company to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login